Michael Lalk

179 papers receiving 6.2k citations

Michael Lalk's Hit Papers

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia 2021 · 276 citations
2760+1+3Years since publication50100150200250

Peers

Michael Lalk
Comparison fields: 5 of 125
  • Infectious Diseases 979
  • Genetics 1.3k
  • Pharmacology 528
  • Biotechnology 229
  • Molecular Biology 2.1k
Replace Haike Antelmann with:
Haike Antelmann Germany
Bradley E. Britigan United States
Michael A. Kohanski United States
Daniel J. Dwyer United States
Tzu‐Ping Ko Taiwan
Rainer Kalscheuer Germany
Kiyoshi Kita Japan
Francois L. Lepine Canada
Lynn G. Dover United Kingdom
Daniel J. Hassett United States
Michael Lalk relative to Haike Antelmann Germany Haike Antelmann's profile →
Citations per field
00.5×2×2.6×
Haike Antelmann · 1×
Citations per year

Countries citing papers authored by Michael Lalk

Since Specialization
Citations

This map shows the geographic impact of Michael Lalk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lalk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lalk more than expected).

Fields of papers citing papers by Michael Lalk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lalk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lalk. The network helps show where Michael Lalk may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Lalk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Lalk Line = papers co-authored together Michael Lalk links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
Hit paper breakdown →
2021276
2 2012197
3 2012165
4 2010155
5 2014155
6 2010154
7 2005130
8 2010118
9 2019104
10 200599
11 201195
12 200594
13 200994
14 201594
15 201092
16 201392
17 200890
18 201190
19 200886
20 200886

About Michael Lalk

Michael Lalk is a scholar working on Genetics, Pharmacology, Infectious Diseases, Molecular Biology and Organic Chemistry, having authored 181 papers that have together received 6.3k indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (45 papers), Antimicrobial Resistance in Staphylococcus (20 papers), Microbial Natural Products and Biosynthesis (18 papers), Microbial Metabolic Engineering and Bioproduction (13 papers), Synthesis and Biological Evaluation (11 papers), Synthesis and biological activity (11 papers), Enzyme Catalysis and Immobilization (10 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). The work is most often cited by research in Infectious Diseases (979 citations), Genetics (1.3k citations), Pharmacology (528 citations), Biotechnology (229 citations) and Molecular Biology (2.1k citations). Michael Lalk has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Manuel Liebeke, Michael Hecker, Ulrike Lindequist, Hanna Meyer, Karen Methling, Timo H. J. Niedermeyer, Peter Langer, Annett Mikolasch, Susanne Engelmann and Dörte Becher. Their work appears in journals such as Journal of Bacteriology, Applied Microbiology and Biotechnology, Bioorganic & Medicinal Chemistry, Scientific Reports and International Journal of Medical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact